{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:59:23Z","timestamp":1762523963135,"version":"build-2065373602"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Research Development Project between Shenkang and United Imaging on Clinical Research and Translation","award":["SKLY2022CRT201]"],"award-info":[{"award-number":["SKLY2022CRT201]"]}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2708500"],"award-info":[{"award-number":["24QA2708500"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Rising Stars of Medical Talent Youth Development Program","award":["SHWRS(2023)-062"],"award-info":[{"award-number":["SHWRS(2023)-062"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J08333"],"award-info":[{"award-number":["2025J08333"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02000-9","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:53:18Z","timestamp":1762523598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic dysfunction\u2013associated fatty liver disease with coronary CT angiography-derived plaque characteristics and cardiovascular events"],"prefix":"10.1186","volume":"25","author":[{"given":"Jin-jin","family":"Wang","sequence":"first","affiliation":[]},{"given":"Xiao-lan","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Xin-wei","family":"Tao","sequence":"additional","affiliation":[]},{"given":"Meng-su","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Yi-ding","family":"Ji","sequence":"additional","affiliation":[]},{"given":"Jian-jun","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Meng-meng","family":"Yu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"2000_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"7","key":"2000_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S2468-1253(22)00127-3","volume":"7","author":"XL Zhang","year":"2022","unstructured":"Zhang XL, Fan JG, Wei L, Shi JP, Zheng MH. Promoting the term MAFLD: China in action. Lancet Gastroenterol Hepatol. 2022;7(7):598.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"14","key":"2000_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350.","journal-title":"N Engl J Med"},{"issue":"10290","key":"2000_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"7 Pt 2","key":"2000_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jcmg.2018.07.020","volume":"12","author":"T Finck","year":"2019","unstructured":"Finck T, Hardenberg J, Will A, Hendrich E, Haller B, Martinoff S, Hausleiter J, Hadamitzky M. 10-Year Follow-Up after coronary computed tomography angiography in patients with suspected coronary artery disease. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1330\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"2000_CR6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","volume":"359","author":"JM Miller","year":"2008","unstructured":"Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359(22):2324\u201336.","journal-title":"N Engl J Med"},{"issue":"38","key":"2000_CR7","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","volume":"44","author":"C Antoniades","year":"2023","unstructured":"Antoniades C, Tousoulis D, Vavlukis M, Fleming I, Duncker DJ, Eringa E, Manfrini O, Antonopoulos AS, Oikonomou E, Padr\u00f3 T, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers. Eur Heart J. 2023;44(38):3827\u201344.","journal-title":"Eur Heart J"},{"key":"2000_CR8","doi-asserted-by":"crossref","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, Margaritis M, Shirodaria C, Kampoli AM, Akoumianakis I, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9(398).","DOI":"10.1126\/scitranslmed.aal2658"},{"issue":"10151","key":"2000_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","volume":"392","author":"EK Oikonomou","year":"2018","unstructured":"Oikonomou EK, Marwan M, Desai MY, Mancio J, Alashi A, Hutt Centeno E, Thomas S, Herdman L, Kotanidis CP, Thomas KE, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392(10151):929\u201339.","journal-title":"Lancet"},{"issue":"43","key":"2000_CR10","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","volume":"40","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Williams MC, Kotanidis CP, Desai MY, Marwan M, Antonopoulos AS, Thomas KE, Thomas S, Akoumianakis I, Fan LM, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40(43):3529\u201343.","journal-title":"Eur Heart J"},{"issue":"9","key":"2000_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/jamacardio.2018.1997","volume":"3","author":"M Goeller","year":"2018","unstructured":"Goeller M, Achenbach S, Cadet S, Kwan AC, Commandeur F, Slomka PJ, Gransar H, Albrecht MH, Tamarappoo BK, Berman DS, et al. Pericoronary adipose tissue computed tomography Attenuation and High-Risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease. JAMA Cardiol. 2018;3(9):858\u201363.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"2000_CR12","doi-asserted-by":"publisher","first-page":"qyaf079","DOI":"10.1093\/ehjimp\/qyaf079","volume":"3","author":"H Yamaura","year":"2025","unstructured":"Yamaura H, Otsuka K, Ishikawa H, Hojo K, Matsumoto K, Fujisawa N, Okamoto A, Yamaguchi T, Kagawa S, Shimada T, et al. High levels of pericoronary adipose tissue inflammation are associated with coronary atherosclerosis independent of epicardial adipose tissue volume in patients with chronic coronary syndrome. Eur Heart J Imaging Methods Pract. 2025;3(2):qyaf079.","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2000_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2016.11.004","volume":"67","author":"HJ Lee","year":"2017","unstructured":"Lee HJ, Lee CH, Kim S, Hwang SY, Hong HC, Choi HY, Chung HS, Yoo HJ, Seo JA, Kim SG, et al. Association between vascular inflammation and non-alcoholic fatty liver disease: analysis by (18)F-fluorodeoxyglucose positron emission tomography. Metabolism. 2017;67:72\u20139.","journal-title":"Metabolism"},{"issue":"11","key":"2000_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/eurheartj\/ehr014","volume":"32","author":"TS Genders","year":"2011","unstructured":"Genders TS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, Galema TW, Meijboom WB, Mollet NR, de Feyter PJ, et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J. 2011;32(11):1316\u201330.","journal-title":"Eur Heart J"},{"issue":"41","key":"2000_CR15","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1093\/eurheartj\/ehy530","volume":"39","author":"TA Fairbairn","year":"2018","unstructured":"Fairbairn TA, Nieman K, Akasaka T, N\u00f8rgaard BL, Berman DS, Raff G, Hurwitz-Koweek LM, Pontone G, Kawasaki T, Sand NP, et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE registry. Eur Heart J. 2018;39(41):3701\u201311.","journal-title":"Eur Heart J"},{"issue":"3","key":"2000_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"6","key":"2000_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","volume":"10","author":"S Abbara","year":"2016","unstructured":"Abbara S, Blanke P, Maroules CD, Cheezum M, Choi AD, Han BK, Marwan M, Naoum C, Norgaard BL, Rubinshtein R, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American society for cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr. 2016;10(6):435\u201349.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"8","key":"2000_CR18","doi-asserted-by":"publisher","first-page":"e007657","DOI":"10.1161\/CIRCIMAGING.118.007657","volume":"11","author":"DO Bittner","year":"2018","unstructured":"Bittner DO, Mayrhofer T, Puchner SB, Lu MT, Maurovich-Horvat P, Ghemigian K, Kitslaar PH, Broersen A, Bamberg F, Truong QA, et al. Coronary computed tomography Angiography-Specific definitions of High-Risk plaque features improve detection of acute coronary syndrome. Circ Cardiovasc Imaging. 2018;11(8):e007657.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"2000_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00330-019-06400-8","volume":"30","author":"M Yu","year":"2020","unstructured":"Yu M, Dai X, Deng J, Lu Z, Shen C, Zhang J. Diagnostic performance of perivascular fat Attenuation index to predict hemodynamic significance of coronary stenosis: a preliminary coronary computed tomography angiography study. Eur Radiol. 2020;30(2):673\u201381.","journal-title":"Eur Radiol"},{"issue":"5","key":"2000_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2214\/AJR.06.0992","volume":"188","author":"Y Kodama","year":"2007","unstructured":"Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188(5):1307\u201312.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2000_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1440-1746.2008.05420.x","volume":"23","author":"EK Speliotes","year":"2008","unstructured":"Speliotes EK, Massaro JM, Hoffmann U, Foster MC, Sahani DV, Hirschhorn JN, O\u2019Donnell CJ, Fox CS. Liver fat is reproducibly measured using computed tomography in the Framingham heart study. J Gastroenterol Hepatol. 2008;23(6):894\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"2000_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173\u201382.","journal-title":"J Pers Soc Psychol"},{"issue":"4","key":"2000_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3758\/BF03206553","volume":"36","author":"KJ Preacher","year":"2004","unstructured":"Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36(4):717\u201331.","journal-title":"Behav Res Methods Instrum Comput"},{"issue":"5","key":"2000_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jhep.2017.12.012","volume":"68","author":"SB Lee","year":"2018","unstructured":"Lee SB, Park GM, Lee JY, Lee BU, Park JH, Kim BG, Jung SW, Jeong ID, Bang SJ, Shin JW, et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study. J Hepatol. 2018;68(5):1018\u201324.","journal-title":"J Hepatol"},{"key":"2000_CR25","doi-asserted-by":"publisher","first-page":"1109673","DOI":"10.3389\/fendo.2023.1109673","volume":"14","author":"F Lei","year":"2023","unstructured":"Lei F, Wang XM, Wang C, Huang X, Liu YM, Qin JJ, Zhang P, Ji YX, She ZG, Cai J, et al. Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China. Front Endocrinol (Lausanne). 2023;14:1109673.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2000_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2016.06.001","volume":"151","author":"DH Sinn","year":"2016","unstructured":"Sinn DH, Cho SJ, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW, Guallar E, Cho J, et al. Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis. Gastroenterology. 2016;151(3):481\u2013e488481.","journal-title":"Gastroenterology"},{"key":"2000_CR27","doi-asserted-by":"publisher","first-page":"154779","DOI":"10.1016\/j.metabol.2021.154779","volume":"120","author":"S Liu","year":"2021","unstructured":"Liu S, Wang J, Wu S, Niu J, Zheng R, Bie L, Xin Z, Wang S, Lin H, Zhao Z, et al. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis. Metabolism. 2021;120:154779.","journal-title":"Metabolism"},{"key":"2000_CR28","doi-asserted-by":"crossref","unstructured":"Cai X, Su X, Zhang Y, Wang S, Pan Y, Jin A, Jing J, Sun J, Mei L, Meng X, et al. Metabolic dysfunction-associated fatty liver disease is associated with the presence of coronary atherosclerotic plaques and plaque burden. Hellenic J Cardiol. 2024.","DOI":"10.1016\/j.hjc.2024.06.002"},{"issue":"3","key":"2000_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiol.14140933","volume":"274","author":"SB Puchner","year":"2015","unstructured":"Puchner SB, Lu MT, Mayrhofer T, Liu T, Pursnani A, Ghoshhajra BB, Truong QA, Wiviott SD, Fleg JL, Hoffmann U, et al. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology. 2015;274(3):693\u2013701.","journal-title":"Radiology"},{"issue":"9","key":"2000_CR30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut. 2020;69(9):1691\u2013705.","journal-title":"Gut"},{"issue":"5","key":"2000_CR31","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.diabet.2023.101468","volume":"49","author":"S Chen","year":"2023","unstructured":"Chen S, Xue H, Huang R, Chen K, Zhang H, Chen X. Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke. Diabetes Metab. 2023;49(5):101468.","journal-title":"Diabetes Metab"},{"key":"2000_CR32","doi-asserted-by":"crossref","unstructured":"Vaz K, Kemp W, Majeed A, Lubel J, Magliano DJ, Glenister KM, Bourke L, Simmons D, Roberts SK. NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia. Hepatol Int. 2024.","DOI":"10.1007\/s12072-024-10706-1"},{"issue":"3","key":"2000_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"3","key":"2000_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/hep.28253","volume":"63","author":"VW Wong","year":"2016","unstructured":"Wong VW, Wong GL, Yeung JC, Fung CY, Chan JK, Chang ZH, Kwan CT, Lam HW, Limquiaco J, Chim AM, et al. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. Hepatology. 2016;63(3):754\u201363.","journal-title":"Hepatology"},{"issue":"1","key":"2000_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcct.2024.10.013","volume":"19","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Yang S, West H, Tomlins P, Hoshino M, Murai T, Hwang D, Shin ES, Doh JH, Nam CW, et al. Association of coronary inflammation with plaque vulnerability and fractional flow reserve in coronary artery disease. J Cardiovasc Comput Tomogr. 2025;19(1):32\u20139.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"16","key":"2000_CR36","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685\u201395.","journal-title":"N Engl J Med"},{"issue":"6","key":"2000_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cgh.2018.11.037","volume":"17","author":"ZP Fricker","year":"2019","unstructured":"Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT. Liver fat is associated with markers of inflammation and oxidative stress in analysis of data from the Framingham heart study. Clin Gastroenterol Hepatol. 2019;17(6):1157\u2013e11641154.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"2000_CR38","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jcmg.2022.04.016","volume":"15","author":"SE Lee","year":"2022","unstructured":"Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, et al. Association between changes in perivascular adipose tissue density and plaque progression. JACC Cardiovasc Imaging. 2022;15(10):1760\u20137.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"2000_CR39","doi-asserted-by":"publisher","first-page":"8111","DOI":"10.1007\/s00330-022-08904-2","volume":"32","author":"MM Yu","year":"2022","unstructured":"Yu MM, Tang XL, Zhao X, Chen YY, Xu ZH, Wang QB, Zeng MS. Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study. Eur Radiol. 2022;32(12):8111\u201321.","journal-title":"Eur Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02000-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:53:22Z","timestamp":1762523602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-02000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02000-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the ethics committee of Zhongshan Hospital, Fudan University, Zhongshan Hospital (Xiamen), Fudan University, and Suzhou Ninth People\u2019s Hospital, and informed consent was acquired by written or telephone consent. All methods were carried out in accordance with relevant guidelines and regulations of the Declaration of Helsinki. All informed consent was obtained from the participants and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}